l.diallo
TL2 · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 21 October 2024 · last posted 4d
63Posts here
0Topics
1Solutions
143Likes received
134Likes given
17Badges
134Days visited
1.1kPosts read
Recent activity
Full stream-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #23 · Compounds › Oral incretins · 24 Jul 2026 · 5 likes Thank you — that answers what I came here to find out.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #94 · Evidence › Journal club · 21 Jul 2026 · 7 likes What I would want before treating SUSTAIN 6 as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
-
Pages past their review date, listed — does this still hold? Replied, post #53 · Meta › Wiki maintenance · 15 Jul 2026 · 0 likes Housekeeping: three documents now carry the same paragraph verbatim because it was copied rather than linked. One of them should hold it and the other two should point…
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #17 · Analytics › HPLC & UHPLC · 12 Jul 2026 · 0 likes Thank you for the correction. I would rather find out here than later.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #66 · Analytics › Home & field testing · 8 Jul 2026 · 6 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #24 · Compounds › Semaglutide · 26 Jun 2026 · 7 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #99 · Outcomes › Body composition · 20 Jun 2026 · 0 likes Worth separating two things that post #95 runs together. Where I would push back on the Lean mass preservation consensus is the confidence, not the direction. The…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #30 · Sourcing › Independent verification · 20 Jun 2026 · 14 likes What a supplier does when asked is itself information, and it is information that a chromatogram cannot provide. The uncertainty is in the assumption, not in the…
-
About the Mass spectrometry category Replied, post #3 · Analytics › Mass spectrometry · 13 Jun 2026 · 23 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #46 · Practice › Dosing & titration · 22 May 2026 · 21 likes Taking post #43 at face value and following it one step further. The starting dose in most of these programmes is a tolerance step and produces little effect by design.…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #25 · Compounds › Repair & healing peptides · 14 May 2026 · 33 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Request: show the solution author in the topic list — what changed since Replied, post #88 · Meta › Feature requests · 4 May 2026 · 5 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…